Ref ID: 18563
Author:
A.A. Colombo (1), C. Pascutto (1), E. Marchioni (2),
F. Ripamonti (1), A. Di Matteo (1), F. Baldanti (1), M. Furione (1),
E.P. Alessandrino (1)
Author address:
(1)Fondazione IRCCS Policlinico San Matteo (Pavia, IT);
(2)Fondazione Casimiro Mondino (Pavia, IT)
Full conference title:
Annual Meeting of the EBMT, 38th
Abstract:
Aim of study was to identify if encephalitis represents an emerging complication in patients receiving allogeneic Hemopoietic
stem cells Transplantation (HSCT).
Methods: To identify the occurrence, the spectrum and the
risk factors inducing neurological diseases, we carried out a
retrospective cohort study including 391 adult patients followed
up after allogeneic HSCT. All patients were affected by oncohematological diseases and received transplantation between
January 1997 and June 2011. One hundred nine patients received an in vivo T depletion by ATG or Alemtuzumab.
Results: Encephalitis was documented in 18/391 patients
(4,6%) and occurred as an early complication in 10/18 pts. The
time-trend of encephalitis incidence is illustrated in Figure 1,
showing a fast increase since 2008. The percentage of patients
receiving T depletion in the same period is also indicated. Vascular diseases were the most frequent causes of encephalitis
(39%). Infectious encephalitis was reported in 11% of patients.
Detected agents were represented by: CMV 1 pt; HHV6 1 pt;
Aspergillus 2 pts, and Pseudomonas 1pt. Two patients developed a late toxic encephalic disease related to radiotherapy, one
patient had a cerebral vasculitis and one a posterior reversible
encephalopathy. The etiology of encephalitis was not identifi ed
in 3 patients. Sixteen patient affected by encephalitis died, but
encephalitis was the direct cause of death in only 13 patients.
Univariate logistic regression models for potential risk factors
identifi ed T-cell depletion (OR=7.5, p=0.001), time of transplant
(3-year calendar periods of transplant, linear trend between
1997-2011) (OR=2.3, p=0.001) and unrelated donor (OR=3.5,
p=0.001), as signifi cant risk factors. In multivariate logistic analysis including also disease status at transplantation, conditioning regimen and acute Graft versus Host Disease, T-depletion
(OR=3.9, p=0.017) and time of transplant (OR=2.5, p= 0.002)
were the only signifi cant risk factors for encephalitis.
Conclusions: Our analysis confi rms a strong association
between the use of in vivo T cell depletion and risk of encephalitis. Moreover, the increasing time-trend in incidence of
encephalitis could be associated to a more frequent use of
T depletion in our Centre in the last decade.
Abstract Number: P643
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a